GANG LIN, L. AC
Acupuncture at Murray St, Flushing, NY
License number
New York 0001404
Category
Acupuncture
Type
Acupuncturist
Address
Address
4011 Murray St, Flushing, NY 11354
Phone
(917) 981-8767
Personal information
See more information about GANG LIN at radaris.comName
Address
Phone
7238 Loubet St, Forest Hills, NY 11375
13720 45Th Ave APT 4P, Flushing, NY 11355
229 Chrystie St APT 822, New York, NY 10002
1 Lynwood Rd, Scarsdale, NY 10583
19411 56Th Ave, Fresh Meadows, NY 11365
Organization information
See more information about GANG LIN at bizstanding.comGANG LIN ACUPUNCTURE, PC
C/O Gang Lin 40-11 Murray St, Flushing, NY 11354
Registration:
Oct 1, 2014
State ID:
4644321
Business type:
DOMESTIC PROFESSIONAL CORPORATION
Professional information
Gang Lin - Elmhurst, NY
Work:
World Financial Group Inc
Independent Representative AFFILIATES
Member AFFILIATES
Member World Financial Group Inc - Manhattan, NY
Accounts Payable Clerk Private Tutor
Independent Representative AFFILIATES
Member AFFILIATES
Member World Financial Group Inc - Manhattan, NY
Accounts Payable Clerk Private Tutor
Education:
UNIVERSITY AT BUFFALO, STATE UNIVERSITY OF NEW YORK
Management HUNTER COLLEGE, CITY UNIVERSITY OF NEW YORK
Management HUNTER COLLEGE, CITY UNIVERSITY OF NEW YORK
Gang Lin, Flushing NY - LAC
Specialties:
Acupuncture
Address:
4011 Murray St, Flushing 11354
Languages:
English
Proteasome Inhibitors And Their Use In Treating Pathogen Infection And Cancer
US Patent:
2011011, May 19, 2011
Filed:
Aug 25, 2008
Appl. No.:
12/674820
Inventors:
Carl Nathan - Larchmont NY, US
Gang Lin - Forest Hills NY, US
Gang Lin - Forest Hills NY, US
Assignee:
CORNELL RESEARCH FOUNDATION, INC. - Ithaca NY
International Classification:
A61K 31/41, A61K 31/422, A61K 31/427, A61K 31/4245, A61K 31/433, A61K 31/4439, A61K 31/501, A61K 31/506, A61K 31/497, C07D 419/04, A61P 35/00, A61P 31/06, A61P 31/00, A61P 31/04, A61P 31/08
US Classification:
51425205, 514360, 514378, 514374, 514365, 514372, 514364, 514361, 514362, 514342, 514256, 51425505, 548122, 514380, 514376, 514377, 514369, 514370
Abstract:
The present invention relates to proteasome inhibitors and their use in methods of treating a subject for a pathogen infection or cancer. The methods involve administering to the subject a compound of Formula (I). (I) where: Q is Formula or Formula, where the crossing dashed line illustrates the bond formed joining Q to the rest of the compound of Formula (I). The remainder of substituents of the compound of Formula (I) are defined in the present application.